A new class of molecules called acyldepsipeptides-ADEPs-may provide a new way to attack bacteria that have developed resistance to antibiotics. Researchers at Brown and MIT have discovered a way to increase the potency of ADEPs by up to ...
Fundacion MEDINA has entered into a contract research collaboration with Cubist Pharmaceuticals to discover novel antibiotics from Cubist's and MEDINA's proprietary and natural product libraries. The alliance will be focused on going ...
Tags: Research Collaboration, Cubist's drug, anti-bacterial drugs